Therapeutic Asset Ratings

228 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Iruplinalib Non-Small Cell Lung Carcinoma	Tianjin Medical University Cancer Institute and Hospital	P2	NR (0)
Against Her 2-Adc Drug Breast Cancer	Tianjin Medical University Cancer Institute and Hospital		NR (0)
Sk-Nk Cancer	Tianjin Medical University Cancer Institute and Hospital	P1/2	NR (0)

Showing 226 to 228 of 228 assets

PreviousPage 10 of 10Next